Missouri Court of Appeals Rewrites Part of Proposed Stem Cell Amendment
At a decision at the Missouri Court of Appeals, the court has decided to rewrite part of a proposed constitutional amendment banning a particular type of embryonic stem cell research. However, the sponsoring group, Cures Without Cloning, would have to turn in about 150,000 signatures by Sunday.
At issue before the appellate court was a ballot summary of the proposal, written by Secretary of State Robin Carnahan and it was designed to explain the proposed amendment to voters. When Carnahan released her summary language in October, supporters of the proposed amendment said it was inaccurate and could turn voters against the measure. Cole County Circuit Judge Patricia Joyce agreed in February and rewrote the ballot summary. Supporters of the original stem cell research amendment led by the Missouri Coalition for Lifesaving Cures appealed the decision.
Cures Without Cloning officials were pleased that part of Carnahan’s statement was ruled insufficient and unfair but said they planned to appeal to the state Supreme Court because the appellate court did not rule that the secretary of state violated the group’s constitutional rights.
Supporters of stem cell research saw the court’s decision as a step toward creating viable avenues to pursue treatments for sufferers of diseases such as Parkinson’s, cancer and sickle cell.
Source: Columbia Missourian
Filed under General Law
You may also like to read
- Future of Life Sciences Research Board To Be Decided Soon
- California Stem Cell Funding Delayed by Lawsuits
- Cell Phone Spam Class Action Lawsuit Settlement
- Top Articles of This Fortnight
- Best of The Fortnight Ending 20th November 2005
- Fresno To Go For Settlement In Lawsuit For Violating The Fourteenth Amendment
- St. Louis Judge Approved Enterprise Leasing Co. Class Action Settlement
- Proposed Class Action Lawsuit Filed Against Wal-Mart
- Class Action Status Rejected in Assaults Case
- Class Action Lawsuit Filed Against QC Holdings Inc.
































